ATE197396T1 - Zusammensetzung und verfahren zur förderung von transdermaler elektrotransport-darreichung - Google Patents

Zusammensetzung und verfahren zur förderung von transdermaler elektrotransport-darreichung

Info

Publication number
ATE197396T1
ATE197396T1 AT95925470T AT95925470T ATE197396T1 AT E197396 T1 ATE197396 T1 AT E197396T1 AT 95925470 T AT95925470 T AT 95925470T AT 95925470 T AT95925470 T AT 95925470T AT E197396 T1 ATE197396 T1 AT E197396T1
Authority
AT
Austria
Prior art keywords
electrotransport
agent
composition
electrical transport
transdermal electrical
Prior art date
Application number
AT95925470T
Other languages
English (en)
Inventor
J Richard Gyory
Original Assignee
Alza Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Alza Corp filed Critical Alza Corp
Application granted granted Critical
Publication of ATE197396T1 publication Critical patent/ATE197396T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0002—Galenical forms characterised by the drug release technique; Application systems commanded by energy
    • A61K9/0009—Galenical forms characterised by the drug release technique; Application systems commanded by energy involving or responsive to electricity, magnetism or acoustic waves; Galenical aspects of sonophoresis, iontophoresis, electroporation or electroosmosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Preparation (AREA)
  • Electrotherapy Devices (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
AT95925470T 1994-07-13 1995-06-29 Zusammensetzung und verfahren zur förderung von transdermaler elektrotransport-darreichung ATE197396T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US27461994A 1994-07-13 1994-07-13
PCT/US1995/008384 WO1996002232A1 (en) 1994-07-13 1995-06-29 Composition and method for enhancing transdermal electrotransport agent delivery

Publications (1)

Publication Number Publication Date
ATE197396T1 true ATE197396T1 (de) 2000-11-11

Family

ID=23048961

Family Applications (1)

Application Number Title Priority Date Filing Date
AT95925470T ATE197396T1 (de) 1994-07-13 1995-06-29 Zusammensetzung und verfahren zur förderung von transdermaler elektrotransport-darreichung

Country Status (7)

Country Link
US (1) US5668170A (de)
EP (1) EP0804155B1 (de)
JP (2) JP4090072B2 (de)
AT (1) ATE197396T1 (de)
DE (1) DE69519393T2 (de)
ES (1) ES2153485T3 (de)
WO (1) WO1996002232A1 (de)

Families Citing this family (60)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6956032B1 (en) 1986-04-18 2005-10-18 Carnegie Mellon University Cyanine dyes as labeling reagents for detection of biological and other materials by luminescence methods
WO1996015826A1 (en) * 1994-11-17 1996-05-30 Alza Corporation Composition and method for enhancing electrotransport agent delivery
AU701737B2 (en) * 1995-04-07 1999-02-04 Novartis Ag Iontophoretic transdermal system for the administration of at least two substances
US5985316A (en) * 1995-04-28 1999-11-16 Alza Corporation Composition and method of enhancing electrotransport agent delivery
US5676648A (en) 1996-05-08 1997-10-14 The Aps Organization, Llp Iontophoretic drug delivery apparatus and method for use
US6385487B1 (en) 1996-05-08 2002-05-07 Biophoretic Therapeutic Systems, Llc Methods for electrokinetic delivery of medicaments
PT910432E (pt) * 1996-06-12 2004-01-30 Alza Corp Electrotransporte melhorado de agentes terapeuticos que tem contra ioes anionicos polibasicos
US6004577A (en) * 1997-08-12 1999-12-21 Murdock; Thomas O. Enhanced electrotransport of therapeutic agents having polybasic anionic counter ions
US6775569B2 (en) * 1997-11-05 2004-08-10 Hisamitsu Pharmaceutical Co., Inc. Electroporation device for in vivo delivery of therapeutic agents
USRE37796E1 (en) 1997-12-16 2002-07-23 Biophoretic Therapeutic Systems, Llc Methods for iontophoretic delivery of antiviral agents
US6374136B1 (en) * 1997-12-22 2002-04-16 Alza Corporation Anhydrous drug reservoir for electrolytic transdermal delivery device
NZ507609A (en) * 1998-04-21 2003-09-26 Infectio Recherche Inc Formulations for the prevention or the treatment of diseases affecting mucosae or skin, or for pregnancy prevention
US6148231A (en) 1998-09-15 2000-11-14 Biophoretic Therapeutic Systems, Llc Iontophoretic drug delivery electrodes and method
US7258869B1 (en) 1999-02-08 2007-08-21 Alza Corporation Stable non-aqueous single phase viscous vehicles and formulations utilizing such vehicle
US7919109B2 (en) 1999-02-08 2011-04-05 Intarcia Therapeutics, Inc. Stable non-aqueous single phase viscous vehicles and formulations utilizing such vehicles
US6792306B2 (en) 2000-03-10 2004-09-14 Biophoretic Therapeutic Systems, Llc Finger-mounted electrokinetic delivery system for self-administration of medicaments and methods therefor
US6477410B1 (en) 2000-05-31 2002-11-05 Biophoretic Therapeutic Systems, Llc Electrokinetic delivery of medicaments
US7127285B2 (en) 1999-03-12 2006-10-24 Transport Pharmaceuticals Inc. Systems and methods for electrokinetic delivery of a substance
US6347246B1 (en) * 2000-02-03 2002-02-12 Axelgaard Manufacturing Company, Ltd. Electrotransport adhesive for iontophoresis device
US6522918B1 (en) 2000-02-09 2003-02-18 William E. Crisp Electrolytic device
ES2240491T3 (es) * 2000-08-01 2005-10-16 Sanofi-Aventis Composicion farmaceutica para la administracion transdermica de befloxatona.
US7465295B2 (en) * 2000-10-20 2008-12-16 Bergeron Michel G Applicator for the delivery of topical formulations into mucosal cavities
US7137975B2 (en) * 2001-02-13 2006-11-21 Aciont, Inc. Method for increasing the battery life of an alternating current iontophoresis device using a barrier-modifying agent
EP1440707A4 (de) * 2001-10-31 2006-05-24 Transcutaneous Tech Inc Iontophorese-vorrichtung
US7099713B2 (en) 2002-06-28 2006-08-29 Battelle Memorial Institute Skin conduction and transport systems
EP1556061B1 (de) * 2002-10-04 2007-04-18 Photokinetix Inc Photokinetische abgabe von biologisch aktiven subtanzen unter verwendung von pulsierendem inkohaerentem licht.
US7731947B2 (en) 2003-11-17 2010-06-08 Intarcia Therapeutics, Inc. Composition and dosage form comprising an interferon particle formulation and suspending vehicle
EP1633431B1 (de) * 2003-06-02 2008-11-12 Power Paper Ltd. Bausatz, vorrichtung und verfahren zur gesteuerten abgabe eines oxidationsmittels in die haut
JP4728631B2 (ja) * 2004-11-30 2011-07-20 Ｔｔｉ・エルビュー株式会社 イオントフォレーシス装置
US7590444B2 (en) * 2004-12-09 2009-09-15 Tti Ellebeau, Inc. Iontophoresis device
US11246913B2 (en) 2005-02-03 2022-02-15 Intarcia Therapeutics, Inc. Suspension formulation comprising an insulinotropic peptide
WO2006083761A2 (en) 2005-02-03 2006-08-10 Alza Corporation Solvent/polymer solutions as suspension vehicles
JP4731931B2 (ja) * 2005-02-03 2011-07-27 Ｔｔｉ・エルビュー株式会社 イオントフォレーシス装置
JP4793806B2 (ja) * 2005-03-22 2011-10-12 Ｔｔｉ・エルビュー株式会社 イオントフォレーシス装置
US8386030B2 (en) 2005-08-08 2013-02-26 Tti Ellebeau, Inc. Iontophoresis device
US20070088331A1 (en) * 2005-08-18 2007-04-19 Transcutaneous Technologies Inc. Method and apparatus for managing active agent usage, and active agent injecting device
CA2619665A1 (en) 2005-09-15 2007-03-22 Tti Ellebeau, Inc. Rod type iontophoresis device
WO2007041526A2 (en) * 2005-09-30 2007-04-12 Transcutaneous Technologies Inc. Iontophoresis apparatus and method to deliver antibiotics to biological interfaces
CA2664589A1 (en) 2005-09-30 2007-04-12 Tti Ellebeau, Inc. Iontophoretic device and method of delivery of active agents to biological interface
US7848801B2 (en) 2005-12-30 2010-12-07 Tti Ellebeau, Inc. Iontophoretic systems, devices, and methods of delivery of active agents to biological interface
CA2651855C (en) 2006-05-30 2011-08-02 Intarcia Therapeutics, Inc. Two-piece, internal-channel osmotic delivery system flow modulator
WO2008021133A2 (en) 2006-08-09 2008-02-21 Intarcia Therapeutics, Inc. Osmotic delivery systems and piston assemblies
EP2123259A1 (de) * 2007-01-16 2009-11-25 Hokkaido University Liposom-zubereitung für die iontophorese mit einem darin eingekapselten antioxidans-bestandteil
ES2402172T3 (es) 2007-04-23 2013-04-29 Intarcia Therapeutics, Inc Formulación en suspensión de péptidos insulinotrópicos y usos de los mismos
US8197844B2 (en) 2007-06-08 2012-06-12 Activatek, Inc. Active electrode for transdermal medicament administration
US8862223B2 (en) 2008-01-18 2014-10-14 Activatek, Inc. Active transdermal medicament patch and circuit board for same
DK2240155T3 (da) 2008-02-13 2012-09-17 Intarcia Therapeutics Inc Indretninger, formuleringer og fremgangsmåder til levering af flere gavnlige midler
ES2655714T3 (es) 2009-02-26 2018-02-21 The University Of North Carolina At Chapel Hill Sistema intervencionista de administración de fármacos
LT2462246T (lt) 2009-09-28 2017-11-27 Intarcia Therapeutics, Inc Esminio stacionaraus vaisto tiekimo greitas įgyvendinimas ir (arba) nutraukimas
US20110087153A1 (en) * 2009-10-13 2011-04-14 Angelov Angel S Transdermal Methods And Systems For The Delivery Of Rizatriptan
US9237961B2 (en) * 2010-04-23 2016-01-19 Medtronic Vascular, Inc. Stent delivery system for detecting wall apposition of the stent during deployment
US20120208755A1 (en) 2011-02-16 2012-08-16 Intarcia Therapeutics, Inc. Compositions, Devices and Methods of Use Thereof for the Treatment of Cancers
US9468682B2 (en) 2013-04-05 2016-10-18 Joint-stock company “High Tech” Compositions and methods for enhancing penetration of biologically active substances into tissues or organs
US9889085B1 (en) 2014-09-30 2018-02-13 Intarcia Therapeutics, Inc. Therapeutic methods for the treatment of diabetes and related conditions for patients with high baseline HbA1c
CA2987766A1 (en) 2015-06-03 2016-12-08 Intarcia Therapeutics, Inc. Implant placement and removal systems
US10501517B2 (en) 2016-05-16 2019-12-10 Intarcia Therapeutics, Inc. Glucagon-receptor selective polypeptides and methods of use thereof
USD840030S1 (en) 2016-06-02 2019-02-05 Intarcia Therapeutics, Inc. Implant placement guide
USD860451S1 (en) 2016-06-02 2019-09-17 Intarcia Therapeutics, Inc. Implant removal tool
IL267736B2 (en) 2017-01-03 2024-03-01 Intarcia Therapeutics Inc Methods comprising continuous administration of a glp-1 receptor agonist and co-adminstration of a drug
USD933219S1 (en) 2018-07-13 2021-10-12 Intarcia Therapeutics, Inc. Implant removal tool and assembly

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4153689A (en) * 1975-06-13 1979-05-08 Takeda Chemical Industries, Ltd. Stable insulin preparation for nasal administration
US4690683A (en) * 1985-07-02 1987-09-01 Rutgers, The State University Of New Jersey Transdermal varapamil delivery device
US4722726A (en) * 1986-02-12 1988-02-02 Key Pharmaceuticals, Inc. Method and apparatus for iontophoretic drug delivery
US4992477A (en) * 1988-04-04 1991-02-12 Warner-Lambert Company Skin moisturizing composition and method of preparing same
US4996193A (en) * 1989-03-03 1991-02-26 The Regents Of The University Of California Combined topical and systemic method of administration of cyclosporine
US5023085A (en) * 1989-11-29 1991-06-11 Pfizer Inc. Transdermal flux enhancers in combination with iontophoresis in topical administration of pharmaceuticals
NZ237489A (en) * 1990-04-18 1995-07-26 Alza Corp Device for electrotransport and reservoir therefor containing a fatty acid as permeation enhancing agent
US5336692A (en) * 1990-06-28 1994-08-09 Medicis Pharmaceutical Corporation Ointment base and method of use
DE69320378T2 (de) * 1992-01-21 1999-04-29 Macrochem Corp Iontophoretische verbesserte Verabreichung von Medikamenten
JPH0616538A (ja) * 1992-07-03 1994-01-25 Japan Tobacco Inc イオントフォレーゼのための薬物吸収用液組成物

Also Published As

Publication number Publication date
JP4090072B2 (ja) 2008-05-28
JP2007314562A (ja) 2007-12-06
EP0804155A1 (de) 1997-11-05
ES2153485T3 (es) 2001-03-01
WO1996002232A1 (en) 1996-02-01
DE69519393D1 (de) 2000-12-14
DE69519393T2 (de) 2001-04-26
US5668170A (en) 1997-09-16
JPH10503184A (ja) 1998-03-24
EP0804155B1 (de) 2000-11-08

Similar Documents

Publication Publication Date Title
ATE197396T1 (de) Zusammensetzung und verfahren zur förderung von transdermaler elektrotransport-darreichung
ATE277671T1 (de) Vorrichtung zur verbesserung der transdermalen abnahme von körperflüssigkeiten
DE69623608D1 (de) Zusammensetzung zur verbesserten elektroübertragunslieferung von wirkstoff
ATE369150T1 (de) Zusammensetzungen, vorrichtung und verfahren zur elektrotransport-wirkstoffabgabe
EP0384266A3 (en) Therapeutic system for the sustained and controlled transdermal or transmucosal delivery of active agents
DE68910520D1 (de) Verfahren zur Verminderung von Hautirritationen bei Anwendung von durchdringungsverstärkenden Arzneimittelzusammensetzungen.
DE69531074D1 (de) Gerät zur Abgabe von Defibrillationsschocks mit verbesserter Wirkungskraft
ZA944608B (en) Incorporating poly-N-vinyl amide in a transdermal system
ATE258068T1 (de) Zusammensetzung, vorrichtung und verfahren zur verbesserten elektrotransport-wirkstoffabgabe
EP0164998A3 (de) Mittel und Verfahren zur Erhöhung der transdermalen und transmembranen Penetration topischer und systemischer Wirkstoffe
IT206292Z2 (it) Garze cosmetiche
ATE369891T1 (de) Lagerstabile iontophorese reservoirelektrode sowie iontophoretisches system
DE3468166D1 (en) Bone cement applicator
AU8132787A (en) Penetration enhancers for transdermal delivery of systemic agents
BR9810554A (pt) Aroil piperazinas para regular a atividade sexual
PT87345A (pt) Processo para a fabricacao de um emplastro para a administracao controlada de substancias activas a pele
DE69623155D1 (de) Verfahren zur transdermalen Verabreichung von Medikamenten
EP0416034A4 (en) Penetration enhancers for transdermal delivery of systemic agent
DE69613370D1 (de) Zusammensetzung und verfahren zur verstärkung von elektrotransport-wirkstoffzufuhr
DE58904913D1 (de) Verfahren zur aufbereitung und zur dosierten abgabe von mischfutter an mehrere abgabestellen und vorrichtung zur durchfuehrung des verfahrens.
ATE20313T1 (de) Elektrotherapeutische vorrichtung.
EP0448299A3 (en) Method and composition for increased skin concentration of active agents by iontophoresis
CA2190370A1 (en) Composition and method for enhancing transdermal electrotransport agent delivery
EP0449463A3 (en) Method and composition for iontophoresis
EP0325616A4 (de) Durchdringungserhöhende mittel für transdermale verabreichung systemischer mittel.

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties